Quantcast
Get breaking news alerts via email

Click here to manage your alerts
Hatch's 'little deal'
This is an archived article that was published on sltrib.com in 2013, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

If anyone still feels that their interests are being well served by our elected officials, you are seriously deluded.

The Jan. 20 front page of The New York Times: "Fiscal Footnote: Big Senate Gift to Drug Maker" outlines how our very own Sen. Orrin Hatch placed a rider in the recently passed "fiscal cliff" bill that gave a huge windfall to drugmaker Amgen. This "little deal" will cost Medicare, and thus taxpayers, $500 million.

Now, I am certain that the good senator's decision was not swayed by the $59,000 he received from Amgen since 2007. After all, that is only a small part of the $5 million the company distributed to members of Congress through its army of 74 lobbyists.

Then, of course, there are also the untold additional amounts given by pharmaceutical groups, including Amgen, to Utah Families Foundation, OrrinPAC and Freedom Path, which sponsored advertisements attacking Hatch's opponent.

I thought Congress was interested in cutting spending and reducing our debt, but it appears that its members continue to focus only on feathering their own nests.

At what point do we become outraged enough to stop this nonsense?

George Mantes

Salt Lake City

Article Tools

 Print Friendly
 
  • Search Obituaries
  • Place an Obituary

  • Search Cars
  • Search Homes
  • Search Jobs
  • Search Marketplace
  • Search Legal Notices

  • Other Services
  • Advertise With Us
  • Subscribe to the Newspaper
  • Login to the Electronic Edition
  • Frequently Asked Questions
  • Contact a newsroom staff member
  • Access the Trib Archives
  • Privacy Policy
  • Missing your paper? Need to place your paper on vacation hold? For this and any other subscription related needs, click here or call 801.204.6100.